News

IDT – Medicinal Cannabis Strategic Update

August 29, 2019

IDT (ASX: IDT): Has posted its Medicinal Cannabis Strategic Update. To read a copy, please click here.

Read More »

IDT 2019 Annual Report

August 29, 2019

IDT (ASX: IDT); Has posted its 2019 Annual Report. The report can be read here.

Read More »

FDA revises IDT’s Facility Inspection Classification

August 28, 2019

IDT (ASX: IDT): FDA revises IDT’s Facility Inspection Classification. To read more about this news, click here.

Read More »

IDT Secures its first Medicinal Cannabis Manufacturing Permit from the Office of Drug Control

August 28, 2019

IDT (ASX: IDT) Secures its first Medicinal Cannabis Manufacturing Permit from the Office of Drug Control Read more about this update here.

Read More »

IDT secures Medicinal Cannabis Manufacturing Licence

May 20, 2019

IDT Australia Ltd (ASX: IDT) secures Medicinal Cannabis Manufacturing Licence from the Office of Drug Control. Read more about this News item here.

Read More »

IDT Australia Ltd ASX Updates Posted

January 30, 2019

IDT Australia Ltd (ASX: IDT) has posted updates to its ASX Page. ASX Announcements

Read More »

IDT Australia Ltd – ASX Updates Published

December 18, 2018

IDT Australia Ltd (ASX: IDT) has posted updates to its ASX Page.  IDT’s Annual General Meeting Presentation is also available to view on the below link. ASX Announcements

Read More »

On-Market Share Buy-back and Small Parcel Buy-back

October 1, 2018

ASX Announcements  

Read More »

IDT Australia Ltd – ASX Updates

August 27, 2018

IDT Australia Ltd (ASX: IDT) has posted updates to 4E, 4G & Corporate Governance.  IDT’s Annual Report has also available to view on the below link. ASX Announcements Corporate Governance  

Read More »

IDT and Cann Group Medicinal Cannabis Partnership

August 7, 2018

IDT Australia Limited (ASX: IDT) provides the following market update that it has entered into a manufacturing agreement with Cann Group Limited (ASX: CAN). IDT has been contracted to provide manufacturing support in relation to medicinal cannabis‐based product formulations intended for supply to patients in Australia and overseas. “Cann Group has established itself as an…

Read More »